SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Steve Harmon who wrote (1402)9/7/1998 11:21:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Hint 2:

Pasteur Merieux has the results of the recent study of Interleukin-1b flu adjuvant. They are $700,000 under on the 1.3 million shares of CIST they acquired at 75 cents in July.

Pasteur Merieux is a major sponsor of ICAAC.